Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Conditions: Solid Tumor, Adult; Bladder Cancer; Urothelial Carcinoma; Triple-negative Breast Cancer; Lung Cancer; Colorectal Cancer; Gastric Cancer; Ovarian Cancer; Pancreatic Cancer Interventions: Drug: Diagnostic Test: MNPR-101-DFO*-89Zr PET Scan Sponsors: Monopar Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bladder Cancer | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Lung Cancer | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | PET Scan | Research